Counteracting Molecular Pathways Regulating the Reduction of Fear: Implications for the Treatment of Anxiety Diseases

2009 ◽  
pp. 79-103 ◽  
Author(s):  
Andre Fischer ◽  
Li-Huei Tsai
Keyword(s):  
Molecular Pathways

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system

2006 ◽  
Vol 44 (08) ◽  
Author(s):  
C Arnold ◽  
A Sosnowski ◽  
A Schmitt-Gräff ◽  
R Arnold ◽  
HE Blum
Keyword(s):  
Neuroendocrine Tumors ◽  
Molecular Pathways

1697-P: NFIA Differentially Regulates Adipogenesis and Myogenesis through Distinct Molecular Pathways to Ensure Adipocyte Differentiation

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1697-P
Author(s):  
YUTA HIRAIKE ◽  
HIRONORI WAKI ◽  
KANA MIYAKE ◽  
MISATO OGUCHI ◽  
TOSHIMASA YAMAUCHI ◽  
...  
Keyword(s):  
Adipocyte Differentiation ◽  
Molecular Pathways

New insights on molecular pathways utilized by salmonella species in cell binding

10.2741/a121 ◽  
1996 ◽  
Vol 1 (4) ◽  
pp. d131-145 ◽  
Author(s):  
B. A McCormick
Keyword(s):  
Molecular Pathways ◽  
Cell Binding

Molecular pathways of Interferon–Stimulated Gene 15: Implications in cancer

2020 ◽  
Vol 21 ◽  
Author(s):  
Angeles C. Tecalco–Cruz
Keyword(s):  
Posttranslational Modification ◽  
Human Interferon ◽  
Molecular Pathways ◽  
Biological Processes ◽  
Small Protein ◽  
Target Proteins ◽  
Central Elements ◽  
Cancer Types ◽  
Interferon Stimulated Gene 15

Abstract:: Human interferon–stimulated gene 15 (ISG15) is a 15–kDa ubiquitin–like protein that can be detected as either free ISG15 or covalently associated with its target proteins through a process termed ISGylation. Interestingly, extracellular free ISG15 has been proposed as a cytokine–like protein, whereas ISGylation is a posttranslational modification. ISG15 is a small protein with implications in some biological processes and pathologies that include cancer. This review highlights the findings of both free ISG15 and protein ISGylation involved in several molecular pathways, emerging as central elements in some cancer types.

New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways

2016 ◽  
Vol 11 (4) ◽  
pp. 222-259
Author(s):  
John P. Schwerkoske ◽  
Douglas Yee
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Molecular Pathways ◽  
Breast Cancer Therapy

Quercetin in attenuation of ischemic/reperfusion injury: A review

2020 ◽  
Vol 13 ◽  
Author(s):  
Milad Ashrafizadeh ◽  
Saeed Samarghandian ◽  
Kiavash Hushmandi ◽  
Amirhossein Zabolian ◽  
Md Shahinozzaman ◽  
...  
Keyword(s):  
Cell Death ◽  
Cell Membrane ◽  
Blood Supply ◽  
Apoptotic Cell ◽  
Ischemia Reperfusion ◽  
Membrane Integrity ◽  
Therapeutic Effects ◽  
Molecular Pathways ◽  
Cell Membrane Integrity ◽  
Cell Membrane Disruption

Background: Ischemia/reperfusion (I/R) injury is a serious pathologic event that occurs due to restriction in blood supply to an organ, followed by hypoxia. This condition leads to enhanced levels of pro-inflammatory cytokines such as IL-6 and TNF-, and stimulation of oxidative stress via enhancing reactive oxygen species (ROS) levels. Upon reperfusion, blood supply increases, but it deteriorates condition, and leads to generation of ROS, cell membrane disruption and finally, cell death. Plant derived-natural compounds are well-known due to their excellent antioxidant and anti-inflammatory activities. Quercetin is a flavonoid exclusively found in different vegetables, herbs, and fruits. This naturally occurring compound possesses different pharmacological activities making it appropriate option in disease therapy. Quercetin can also demonstrate therapeutic effects via affecting molecular pathways such as NF-B, PI3K/Akt and so on. Methods: In the present review, we demonstrate that quercetin administration is beneficial in ameliorating I/R injury via reducing ROS levels, inhibition of inflammation, and affecting molecular pathways such as TLR4/NF-B, MAPK and so on. Results and conclusion: Quercetin can improve cell membrane integrity via decreasing lipid peroxidation. Apoptotic cell death is inhibited by quercetin via down-regulation of Bax, and caspases, and upregulation of Bcl-2. Quercetin is able to modulate autophagy (inhibition/induction) in decreasing I/R injury. Nanoparticles have been applied for delivery of quercetin, enhancing its bioavailability and efficacy in alleviation of I/R injury. Noteworthy, clinical trials have also confirmed the capability of quercetin in reducing I/R injury.

Sign in / Sign up

Export Citation Format

Share Document